alexa Progress Of R&D Of Chinese Materia Medica To Keep Up With Advances In Technology
ISSN: 2329-6836

Natural Products Chemistry & Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products
August 25-27, 2014 DoubleTree by Hilton Beijing, China

De-an Guo
Symposium: Nat Prod Chem Res
DOI: 10.4172/2329-6836.S1.003
Traditional Chinese medicine (TCM) has over 3000 years of history to treat diseases in China and has played a pivotal role in the Chinese health system. In the past 20 years or so, great progress has been achieved on the modernization of traditional Chinese medicine. Government launched a number of ?heavy-weight? programs and allocated central budget for the development of TCM. Chemistry of Chinese herbal medicines was thoroughly investigated and over 3000 new chemical compounds were isolated and some of them have been in the process of new drug development. TCM pharmaceutical industry is on the rise and growing rapidly with respect to the yearly gross sale and modern facilities. In this lecture, TCM resources, related research institutions and education systems, recent development in Chinese Pharmacopoeia, TCM new drug registration regulations by CFDA, TCM-based drug discovery, government funding sectors, recent research progress achieved will be briefly overviewed, which may help the audience to understand where TCM stands in China. In addition, the current research on the quality standard construction of traditional Chinese medicines will also be introduced with some concrete examples. The future perspective of TCM modernization will be briefly projected.
De-an Guo serves as Director of the State Engineering Laboratory for Traditional Chinese Medicine (TCM) Standardization Technology at the Shanghai Institute of Materia Medica of Chinese Academy of Sciences. His research has centered on TCM analysis, quality and metabolisms. He has published more than 480 papers to date and 320 papers in SCI journals with over 4600 citations. He acted as the editor-in-chief of the 2010 English edition of Chinese Pharmacopoeia. At present, he is Associate Editor, Editor or Editorial Board Member of 16 highly respected international scientific journals, including .
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version